Edgar Filing: CMEA VENTURES VI LP

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

CMEA VENTURES VI LP

2. Issuer Name and Ticker or Trading Symbol
TETRAPHASE PHARMACEUTICALS INC [TTPH]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	__X__ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

(Last)

(First)

(Middle)

1 LETTERMAN DR. BLDG C, SUITE CM500

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2013

(Street)

SAN FRANCISCO, CA 94129

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/25/2013		C		1,693	A	⁽¹⁾	1,693 ⁽²⁾	D
Common Stock	03/25/2013		C		70,376	A	⁽¹⁾	70,376 ⁽³⁾	D
Common Stock	03/25/2013		C		2,208	A	⁽¹⁾	3,901 ⁽²⁾	D
Common Stock	03/25/2013		C		91,795	A	⁽¹⁾	162,171 ⁽³⁾	D
Common Stock	03/25/2013		C		9,250	A	⁽¹⁾	13,151 ⁽²⁾	D
Common Stock	03/25/2013		C		384,613	A	⁽¹⁾	546,784 ⁽³⁾	D
Common Stock	03/25/2013		C		23,639	A	⁽¹⁾	36,790 ⁽²⁾	D
Common Stock	03/25/2013		C		982,275	A	⁽¹⁾	1,529,059 ⁽³⁾	D
Common Stock	03/25/2013		P		14,786	A	$ 7	51,576 ⁽²⁾	D
Common Stock	03/25/2013		P		628,071	A	$ 7	2,157,130 ⁽³⁾	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Series A-1 Convertible Participating Preferred Stock

⁽¹⁾

03/25/2013

49,088

⁽¹⁾

⁽⁴⁾

Common Stock

1,693 ⁽¹⁾ ⁽²⁾

$ 0

Series A-1 Convertible Participating Preferred Stock

⁽¹⁾

03/25/2013

2,040,912

⁽¹⁾

⁽⁴⁾

Common Stock

70,376 ⁽¹⁾ ⁽³⁾

$ 0

Series A-2 Convertible Participating Preferred Stock

⁽¹⁾

03/25/2013

64,027

⁽¹⁾

⁽⁴⁾

Common Stock

2,208 ⁽¹⁾ ⁽²⁾

$ 0

Series A-2 Convertible Participating Preferred Stock

⁽¹⁾

03/25/2013

2,662,059

⁽¹⁾

⁽⁴⁾

Common Stock

91,795 ⁽¹⁾ ⁽³⁾

$ 0

Series B Convertible Participating Preferred Stock

⁽¹⁾

03/25/2013

268,269

⁽¹⁾

⁽⁴⁾

Common Stock

9,250 ⁽¹⁾ ⁽²⁾

$ 0

Series B Convertible Participating Preferred Stock

⁽¹⁾

03/25/2013

11,153,776

⁽¹⁾

⁽⁴⁾

Common Stock

384,613 ⁽¹⁾ ⁽³⁾

$ 0

Series C Convertible Participating Preferred Stock

⁽¹⁾

03/25/2013

685,531

⁽¹⁾

⁽⁴⁾

Common Stock

23,639 ⁽¹⁾ ⁽²⁾

$ 0

Series C Convertible Participating Preferred Stock

⁽¹⁾

03/25/2013

28,485,997

⁽¹⁾

⁽⁴⁾

Common Stock

982,275 ⁽¹⁾ ⁽³⁾

$ 0

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
CMEA VENTURES VI LP 1 LETTERMAN DR. BLDG C, SUITE CM500 SAN FRANCISCO, CA 94129		X
CMEA Ventures VI GmbH & Co. KG 1 LETTERMAN DR. BLDG C, SUITE CM500 SAN FRANCISCO, CA 94129		X
CMEA Ventures VI Management, L.P. 1 LETTERMAN DR. BLDG C, SUITE CM500 SAN FRANCISCO, CA 94129		X
Handelsman Karl D. 1 LETTERMAN DR. BLDG C, SUITE CM500 SAN FRANCISCO, CA 94129		X
Collier David J 1 LETTERMAN DR. BLDG C, SUITE CM500 SAN FRANCISCO, CA 94129		X
Watson James F 1 LETTERMAN DR. BLDG C, SUITE CM500 SAN FRANCISCO, CA 94129		X
Sohail Faysal A. 1 LETTERMAN DR. BLDG C, SUITE CM500 SAN FRANCISCO, CA 94129		X
BARUCH THOMAS R 1 LETTERMAN DR. BLDG C, SUITE CM500 SAN FRANCISCO, CA 94129		X

Signatures

CMEA Ventures VI, L.P. By: CMEA Ventures VI Management, L.P., its General Partner By: /s/ Karl Handelsman, General Partner		03/27/2013
^**Signature of Reporting Person		Date
CMEA Ventures VI, GmbH & CO. KG By: CMEA Ventures VI Management, L.P., its General Partner By: /s/ David Collier, its General Partner		03/27/2013
^**Signature of Reporting Person		Date
CMEA Ventures VI Management, L.P. By: /s/ Faysal Sohail, its General Partner		03/27/2013
^**Signature of Reporting Person		Date
/s/ Karl Handelsman		03/27/2013
^**Signature of Reporting Person		Date
/s/ David Collier		03/27/2013
^**Signature of Reporting Person		Date
/s/ James Watson		03/27/2013
^**Signature of Reporting Person		Date
/s/ Faysal Sohail		03/27/2013
^**Signature of Reporting Person		Date
/s/ Thomas Baruch		03/27/2013
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The Series A-1, Series A-2, Series B and Series C Convertible Preferred Stock converted into Common Stock on a 1-for-29 basis upon the closing of the issuer's initial public offering without payment of consideration.
(2)	Held by CMEA Ventures VI, GmbH & Co. KG. The general partner of CMEA Ventures VI, GmbH & Co. KG is CMEA Ventures VI Management, L.P. The general partners of CMEA Ventures VI Management, L.P. are Karl Handelsman, David Collier, Faysal Sohail, Thomas Baruch and James Watson. CMEA Ventures VI Management, L.P. and each of these individuals exercises shared voting and investment power over the shares held of record by CMEA Ventures VI, GmbH & Co. KG. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
(3)	Held by CMEA Ventures VI, L.P. The general partner of CMEA Ventures VI, L.P. is CMEA Ventures VI Management, L.P. The general partners of CMEA Ventures VI Management, L.P. are Karl Handelsman, David Collier, Faysal Sohail, Thomas Baruch and James Watson. CMEA Ventures VI Management, L.P. and each of these individuals exercises shared voting and investment power over the shares held of record by CMEA Ventures VI, L.P. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
(4)	Not applicable.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.